Markets:

Overview

News

Currencies

International

Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

8.050 -0.220 (-2.66%)

Delayed Quote Updated: 10:51 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

7 A-Rated Biotechs to Buy for the Long Run ↗

December 03, 2021

The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples.

Via InvestorPlace

Analyst Ratings For Prothena Corp ↗

November 19, 2021

Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the follo...

Via Benzinga

Prothena Corp: Q3 Earnings Insights ↗

November 04, 2021

Prothena Corp (NASDAQ:PRTA) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

7 A-Rated Healthcare Stocks to Buy for the Long Haul ↗

November 01, 2021

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future.

Via InvestorPlace

What 8 Analyst Ratings Have To Say About Prothena Corp ↗

September 20, 2021

Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA

Via Benzinga

Expert Ratings For Prothena Corp ↗

September 17, 2021

Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA

Via Benzinga

Expert Ratings For Prothena Corp ↗

September 14, 2021

Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the foll...

Via Benzinga

What 9 Analyst Ratings Have To Say About Prothena Corp ↗

August 09, 2021

Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 ↗

November 19, 2021

Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:

Via Benzinga

Expert Ratings For Prothena Corp ↗

September 30, 2021

Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA

Via Benzinga

Expert Ratings For Prothena Corp ↗

September 27, 2021

Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA

Via Benzinga

Where Prothena Corp Stands With Analysts ↗

July 19, 2021

Within the last quarter, Prothena Corp (NASDAQ:PRTA) has ...

Via Benzinga

With Prothena Up Over 500% This Year, Is It Too Late to Get in? ↗

September 18, 2021

Promising drug candidates could lead to a best-in-class Alzheimer's treatment.

Via The Motley Fool

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Return on Capital Employed Insights for Prothena Corp ↗

September 02, 2021

According to Benzinga Pro, during Q2, Prothena Corp (NASDAQ:PRTA) earned $27.95 million, a 187.04% increase from the preceding quarter. Prothena Corp also posted a total of $60.07...

Via Benzinga

Where Prothena Corp Stands With Analysts ↗

July 13, 2021

Prothena Corp (NASDAQ:PRTA) has observed the following an...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

August 09, 2021

Jefferies raised the price target on Tesla, Inc. (NASDAQ:

Via Benzinga

Recap: Prothena Corp Q2 Earnings ↗

August 05, 2021

Shares of Prothena Corp (NASDAQ:PRTA) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 187.88% year over year to $0...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Why Is Novo Nordisk Buying a Rare-Disease Candidate? ↗

July 24, 2021

The company is mainly known for its diabetes drugs but has some background in rare-disease drugs.

Via The Motley Fool

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

10 Biggest Price Target Changes For Tuesday ↗

July 13, 2021

Wells Fargo lowered C.H. Robinson Worldwide, Inc. (NASDAQ:

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump ↗

July 12, 2021

Toward the end of trading Monday, the Dow traded up 0.34% to 34,987.02 while the NASDAQ rose 0.08% to 14,713.30. The S&P also rose, gaining 0.26% to 4,380.72. The U.S. has the...

Via Benzinga

Topics Stocks

Mid-Day Market Update: Crude Oil Down 1%; Celldex Therapeutics Shares Spike Higher ↗

July 12, 2021

Midway through trading Monday, the Dow traded up 0.28% to 34,967.12 while the NASDAQ rose 0.08% to 14,714.09. The S&P also rose, gaining 0.23% to 4,379.69. The U.S. has the...

Via Benzinga

Topics Stocks

Mid-Morning Market Update: Markets Mostly Higher; Novo Nordisk To Acquire Prothena's ATTR Amyloidosis Program ↗

July 12, 2021

Following the market opening Monday, the Dow traded up 0.32% to 34,981.25 while the NASDAQ fell 0.07% to 14,691.53. The S&P also rose, gaining 0.15% to 4,376.17. The U.S. has...

Via Benzinga

Topics Stocks

Novo Nordisk To Buy Prothena's ATTR Amyloidosis Program For Up To $1.2B ↗

July 12, 2021

Novo Nordisk A/S (NYSE: NVO) will acquire Prothena Corporation plc's (NASDAQ: PRTA) and clinical stage antibody PRX004 and broader ATTR amyloidosis...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 09, 2021

Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock...

Via Benzinga

64 Biggest Movers From Friday ↗

July 12, 2021

Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)...

Via Benzinga

Topics Initial Public Offering

40 Stocks Moving In Friday's Mid-Day Session ↗

July 09, 2021

Gainers Stamps.com Inc. (NASDAQ: STMP) jumped 63.7% to $323.63. Software investment firm Thoma Bravo inked an agreement to acquire e-commerce shipping solutions provider Stamps....

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.